How to choose the best cryptocurrency exchange?

To choose the best exchange, you need to consider factors like security, fees, variety of available cryptocurrencies, ease of use, and deposit/withdrawal options. At Investing.ad, we analyze these factors for each platform.

Are the recommended brokers and exchanges secure?

All brokers and exchanges we recommend comply with strict security standards, including two-factor authentication, cold storage for cryptocurrencies, and financial regulations according to the country. We constantly evaluate their protection measures.

What fees do investment platforms charge?

Fees vary by platform. Cryptocurrency exchanges typically charge between 0.1% and 2% per transaction, while brokers may charge per operation or spread. In our comparisons, we break down all fees so you can choose the most economical option.

Monitorización remota: enfrentando recortes de pagadores y viento a favor de la interoperabilidad

Executive Summary

Sentiment: Cautelosamente negativo a corto plazo (recortes de pagadores), con catalizadores a medio plazo procedentes de la interoperabilidad, analítica clínica y casos de uso de equidad en salud.
Riesgo clave: El endurecimiento de la cobertura de UnitedHealthcare para los códigos RPM amenaza a los proveedores de RPM dependientes de los volúmenes de CPT 99453/99454/99457/99458.
Catalizadores: El empuje de CMS por la interoperabilidad y el trabajo de identidad/autenticación vinculado a Epic podrían reducir la fricción en el onboarding y aumentar la utilización en contratos basados en el valor; estudios de casos de proveedores muestran el valor de engagement del RPM.
Posicionamiento: Preferir nombres expuestos al RPM con reembolso diversificado y fosos competitivos duraderos (DME + plataformas de datos), y vigilar integradores privados de analítica/RPM para posibles M&A a valoraciones distressed.

1) Key Value Signals

Payer pressure: UnitedHealthcare cutting some RPM coverage is a material near-term revenue headwind for CPT-driven vendors; raises consolidation odds and favors DME-linked RPM platforms less reliant on those codes. Digital health accessibility… CHIME
Interoperability/pragmatic partnerships: CMS showcases industry momentum; HealthEx demoed an Epic/CLEAR/MedAllies collaboration to streamline identity and cross-system access—potentially lowering RPM onboarding friction. CMS advances interoperability… Fierce Healthcare
Post-acute visibility: Real Time Medical Systems launched TEAM Insights to surface early clinical deterioration from post-acute EHRs—interventional analytics that can complement RPM signals and reduce readmissions. Turning post-acute visibility… Fierce Healthcare
Health equity and engagement: Mount Sinai reports Spanish-language AI + RPM is boosting patient engagement—evidence that culturally tailored RPM can drive outcomes, important for risk-based contracts. AI builds health equity… Mobi Health News
Capital formation at the edges: Veteran-led J2 Ventures raised a $250M fund for critical tech (AI, comms, sensors)—a potential funding source for defense-grade, secure RPM/telemetry tools. Coding, autonomy… Washington Technology

2) Stocks or Startups to Watch

Nota: Las métricas son direccionales/aproximadas basadas en los últimos datos TTM/FY declarados a 2024–2025. Verificar antes de operar.

ResMed (RMD) — Core sleep/COPD DME with cloud-connected monitoring
- Razonamiento: Foso duradero en dispositivos conectados a la nube (AirView, Brightree), diversificación de pagadores más allá de los códigos CPT de RPM; se beneficia de las tendencias hospital-a-hogar y de datos vinculados a la adherencia. Defensiva frente a los recortes de códigos por parte de pagadores.
- Métricas:
  - P/E: ~25–30 (TTM)
  - P/B: ~6–8
  - Debt-to-Equity: ~0.2–0.3
  - FCF: ~$0.8–1.0B positivo
  - PEG: ~1.5–2.0
- Posición: Comprar en caídas; empresa de calidad con adyacencia al RPM.
Viemed Healthcare (VMD) — Home respiratory care with telemonitoring
- Razonamiento: Small-cap rentable con bajo apalancamiento; modelo adyacente a RPM impulsado por DME y resultados clínicos; menos dependiente de códigos CPT específicos de RPM. Potencial beneficiaria de consolidación.
- Métricas:
  - P/E: ~20–25
  - P/B: ~3–4
  - Debt-to-Equity: <0.2
  - FCF: Positivo (~$20–30M)
  - PEG: ~1.0–1.5
- Posición: Acumular; valor infraseguido con nicho defendible.
Masimo (MASI) — Noninvasive monitoring; expanding hospital-to-home
- Razonamiento: Fuerte propiedad intelectual en oximetría y monitorización; base instalada en hospitales y expansión al hogar proporcionan apalancamiento en RPM. La presión activista tras la adquisición de consumo ha afinado el enfoque en el core.
- Métricas:
  - P/E: ~20–30
  - P/B: ~3
  - Debt-to-Equity: ~0.4–0.6
  - FCF: Positivo (cientos de millones)
  - PEG: ~1.2–1.8
- Posición: Vigilar/Compra selectiva; franquicia de monitorización de calidad con disciplina de capital en mejora.
Teladoc Health (TDOC) — Telehealth + chronic care RPM (ex-Livongo)
- Razonamiento: Trayectoria hacia FCF positivo y gran base de afiliados, pero la exposición al reembolso y la competencia persisten. Los recortes de pagadores aumentan el riesgo de crecimiento a corto plazo; existe optionality en atención basada en valor.
- Métricas:
  - P/E: N/A (beneficio negativo)
  - P/B: ~0.7–1.1
  - Debt-to-Equity: ~0.1–0.2
  - FCF: Positivo (centenares de millones, bajo)
  - PEG: N/A
- Posición: Vigilar; potencial de turnaround pero no entrada clásica de valor hasta que los beneficios mejoren.
iRhythm (IRTC) — Ambulatory cardiac monitoring (Zio) with RPM overlap
- Razonamiento: Demanda estructural para detección de arritmias; persisten la volatilidad del reembolso y los costes de escalado. Palanca hacia diagnósticos habilitados por IA; la postura de los pagadores sigue siendo factor determinante.
- Métricas:
  - P/E: N/A (con pérdidas)
  - P/B: ~6–8
  - Debt-to-Equity: ~0.0–0.2
  - FCF: Cerca del punto de equilibrio a negativo
  - PEG: N/A
- Posición: Vigilar; activo de calidad, pero no valor a los múltiplos actuales.
Real Time Medical Systems (Private) — Interventional analytics in post-acute
- Razonamiento: Se sitúa “al lado” del RPM convirtiendo señales del EHR en acciones que reducen readmisiones. Objetivo de adquisición atractivo para payviders, pagadores o ecosistemas de dispositivos.
- Métricas: P/E, P/B, D/E, FCF, PEG: N/A (privada)
- Posición: Vigilar para inversión estratégica/M&A.
HealthEx (Private) — Interop and identity, built with Epic/CLEAR/MedAllies
- Razonamiento: Reduce la fricción para el acceso multiinstitución y la autenticación; crucial para el onboarding/cumplimiento del RPM. Encaje estratégico con EHRs, tecnología de identidad y pagadores.
- Métricas: P/E, P/B, D/E, FCF, PEG: N/A (privada)
- Posición: Vigilancia temprana; potencial de foso impulsado por asociaciones.

3) What Smart Money Might Be Acting On

Consolidation in RPM: Payer code pressure creates distressed sellers among FFS RPM vendors; strategics with DME platforms (RMD, VMD) or hospital footprints (MASI) can buy analytics/RPM assets cheaply.
Interop/identity rails as enablers: Epic/CLEAR/MedAllies-style integrations become core infra; investors back “picks-and-shovels” that reduce CAC and churn in RPM.
Defense/dual-use telemetry: J2 Ventures’ new $250M fund targeting critical tech suggests crossover interest in secure, reliable remote sensing—overlaps with medical-grade RPM.
Shift to value-based: Providers showcasing engagement/equity gains (Mount Sinai) signal that RPM value will be realized via outcomes-driven risk contracts, not just CPT codes.

Signals and Analysis (Include Sources)

CMS Interoperability and HealthEx-Epic-CLEAR collaboration
- What happened: CMS spotlighted a national provider directory effort, and HealthEx demoed an interoperability platform with Epic, CLEAR and MedAllies, enabling grouped authentication and streamlined access. CMS advances interoperability initiative…
- Why it matters: Identity and access friction is a hidden tax on RPM adoption. These partnerships are a “picks-and-shovels” play that can reduce onboarding costs and time, improving utilization and ROI under value-based models.
UnitedHealth’s RPM coverage shock (context in CHIME report)
- What happened: Industry executives flagged digital health access challenges as RPM companies react to UnitedHealth’s decision to cut some RPM coverage. Digital health accessibility… CHIME
- Why it matters: A near-term revenue reset for CPT-driven RPM vendors; boosts M&A pressure and favors companies with diversified revenue (DME, SaaS, risk-sharing) and positive free cash flow.
Real Time Medical Systems’ TEAM Insights
- What happened: Real Time launched TEAM Insights, using interventional analytics to continuously monitor structured/unstructured post-acute EHR data and detect subtle clinical changes. Turning post-acute visibility…
- Why it matters: Enhances RPM’s clinical utility by pairing device data with EHR context; creates hospital savings via reduced readmissions—budget lines less exposed to RPM fee-for-service reimbursement swings.
Mount Sinai’s AI + RPM for equity
- What happened: CIO Tom Gillette highlighted Spanish-language AI, predictive models, and RPM boosting engagement and access in South Florida’s diverse population. AI builds health equity…
- Why it matters: Demonstrates the patient-retention and outcomes value of culturally tailored RPM—key for capitated and shared-savings contracts.
FDA clearances for portable devices
- What happened: FDA cleared portable imaging devices and a robotic navigation system. FDA clearances… Modern Healthcare
- Why it matters: Not RPM-specific, but continued approval of portable modalities expands the home/outpatient toolkit, strengthening the hospital-to-home trend that underpins RPM economics.
Capital formation: J2 Ventures’ $250M Brookhaven Fund
- What happened: New early-stage fund focused on critical technologies including AI and communications infrastructure. Coding, autonomy…
- Why it matters: Potential dry powder for secure telemetry/RPM infrastructure; defense-grade reliability can be a moat in clinical RPM.
Ecosystem/academic momentum
- What happened: UVA Health eyes a biotech hub to improve access and attract specialists. UVA Health’s Mark Esser…
- Why it matters: Regional hubs accelerate pilots and outcomes data for RPM and analytics—feedstock for payer negotiations and ROIC on digital investments.

4) References

CMS advances interoperability initiative, showcases early look at national provider directory – Fierce Healthcare: https://www.fiercehealthcare.com/health-tech/cms-advances-interoperability-initiative-showcases-provider-directory-meeting-industry
Turning post-acute visibility into TEAM success with actionable insights – Fierce Healthcare: https://www.fiercehealthcare.com/sponsored/turning-post-acute-visibility-team-success-actionable-insights
AI builds health equity one conversation at a time – Mobi Health News: https://www.mobihealthnews.com/video/ai-builds-health-equity-one-conversation-time
Digital health accessibility a struggle for providers: CHIME – Modern Healthcare: https://www.modernhealthcare.com/health-tech/ai/mh-digital-health-tools-patient-access-chime/
FDA clearances: Fujifilm Sonosite, Stereotaxis, Adaptix, Aiomega – Modern Healthcare: https://www.modernhealthcare.com/medical-devices/mh-fda-clearances-fujifilm-sonosite-stereotaxis-adaptix/
Coding, autonomy and a new fund highlight a week of venture moves – Washington Technology: https://www.washingtontechnology.com/companies/2025/11/coding-autonomy-and-new-fund-highlight-week-venture-moves/409492/?oref=wt-homepage-river
UVA Health’s Mark Esser bets on biotech institute to boost access – Modern Healthcare: https://www.modernhealthcare.com/providers/mh-uva-health-mark-esser-biotech-institute/

5) Investment Hypothesis

Short term (0–6 months): Payer reimbursement cuts create volatility for fee-for-service RPM vendors; expect negative revisions and consolidation. Prefer defensive RPM adjacencies (RMD, VMD, MASI) with strong FCF and diversified reimbursement.
Medium term (6–24 months): Interoperability, identity, and analytics partnerships reduce friction and demonstrate outcomes; value-based contracts become the dominant monetization path for RPM. Buyers with capital will acquire distressed RPM assets to bolster home-based ecosystems.
Long term (2–5 years): Hospital-to-home acceleration and culturally tailored engagement (as evidenced by Mount Sinai) support sustained RPM adoption; platforms with device+data moats and payer/provider integrations win.

Investment Thesis

Recommendation: Barbell approach.
- Buy/Accumulate: ResMed (RMD), Viemed (VMD). High-quality fundamentals, low leverage, and RPM-adjacent moats insulated from CPT volatility. Masimo (MASI) as a selective quality add.
- Watch: Teladoc (TDOC), iRhythm (IRTC). Await clearer earnings inflection and reimbursement visibility; consider on material dislocations.
- Private watchlist for strategic optionality: Real Time Medical Systems, HealthEx (interop/identity).
Risk/Reward: Favorable risk-adjusted returns in DME-linked RPM with strong FCF and defensible data networks. Primary risks include broader payer tightening, pricing pressure, and slower-than-expected integration of interop/identity tooling. Catalysts include value-based contract wins, readmission reduction data, and strategic M&A.
Core theme: In RPM, the economic rent flows to platforms that can prove outcomes with minimal operational friction. Interoperability and identity are the rails; DME-linked data networks are the moat.